MD Anderson Cancer Center
Metastatic Colon Cancer Survival – CNL
Dr. Ray DuBois, MD Anderson's provost and executive vice president, talks with Dr. Scott Kopetz, assistant professor in MD Anderson's Department of Gastrointestinal Medical Oncology, about a new study that found novel chemotherapy and biological agents, combined with surgical advances for liver resection have resulted in a dramatic increase in survival for patients with metastatic colon cancer.
This audio is available in a Flash version only and requires an updated Flash player. Please update your Flash player or watch on a device which supports Flash. Flash Player Help . For additional recordings, please visit our online search for additional media resources.

Title: Metastatic Colon Cancer Survival – CNL
Summary: Dr. Ray DuBois, MD Anderson's provost and executive vice president, talks with Dr. Scott Kopetz, assistant professor in MD Anderson's Department of Gastrointestinal Medical Oncology, about a new study that found novel chemotherapy and biological agents, combined with surgical advances for liver resection have resulted in a dramatic increase in survival for patients with metastatic colon cancer.
Keywords:
Transcript: